You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Very high risk MDS

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Myelodysplastic Syndrome (MDS) Trial in Worldwide (sabatolimab, azacitidine, venetoclax)

Active, not recruiting
  • Myelodysplastic Syndrome (MDS)
  • Brasschaat, Belgium
  • +9 more
Jan 19, 2023

AML, MDS, Old Age; Debility Trial in Suzhou (Azacitidine, all trans retinoic acid)

Recruiting
  • AML
  • +3 more
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Dec 27, 2021

MDS Trial (Decitabine/Cedazuridine, Magrolimab)

Not yet recruiting
  • Myelodysplastic Syndromes
  • (no location specified)
Apr 18, 2023

MDS, AML Trial in France (ASTX727, Donor Lymphocyte Infusions)

Recruiting
  • MDS
  • AML
  • Amiens, France
  • +15 more
Jul 21, 2022

Acute Myeloid Leukemia (AML), MDS (MDS) Trial in China (APG-115, Azacitidine, Cytarabine)

Recruiting
  • Acute Myeloid Leukemia (AML)
  • Myelodysplastic Syndromes (MDS)
  • Beijing, Beijing, China
  • +13 more
Aug 16, 2022

Acute Myeloid Leukemia, Adult, MDS Trial in Marseille, Paris, Pierre-Bénite (ABD-3001)

Active, not recruiting
  • Acute Myeloid Leukemia, Adult
  • Myelodysplastic Syndromes
  • Marseille, France
  • +2 more
Jan 19, 2023

Myelodysplastic Syndrome (MDS) Trial in United States (MBG453, Azacitidine, Decitabine)

Recruiting
  • Myelodysplastic Syndrome (MDS)
  • Chandler, Arizona
  • +22 more
Dec 5, 2022

Relapsed/Refractory Hematopoietic Malignancies, Acute Myeloid Leukemia and MDS Trial in Washington, Baltimore (Tumor associated

Recruiting
  • Relapsed/Refractory Hematopoietic Malignancies, Acute Myeloid Leukemia and MDS
  • Tumor associated antigen lymphocytes (TAA-T)
  • Washington, District of Columbia
  • +1 more
Jul 15, 2021

MDS Trial in Worldwide (MBG453, Placebo, Hypomethylating agents)

Active, not recruiting
  • Myelodysplastic Syndromes
  • Duarte, California
  • +46 more
Jan 20, 2023

Very Low Risk, Low Risk, or Intermediate Risk MDS Per IPSS-R Trial in Canada, United States (Etavopivat)

Recruiting
  • Very Low Risk, Low Risk, or Intermediate Risk MDS Per IPSS-R
  • Ocala, Florida
  • +3 more
Jan 30, 2023

MDS Trial (Imetelstat)

Available
  • Myelodysplastic Syndromes
  • (no location specified)
Jun 30, 2023

Prostate Cancer, Newly-Diagnosed Prostate Cancer Trial ([18F]PSMA-1007)

Not yet recruiting
  • Prostate Cancer
  • Newly-Diagnosed Prostate Cancer
  • (no location specified)
Nov 3, 2023

Acute Myeloid Leukemia, Myelodysplastic Tumor Trial (Magrolimab, 7+3, CPX-351)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Neoplasm
  • (no location specified)
Apr 24, 2023

ASCVD, Atherosclerotic Cardiovascular Disease, Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor Trial (Evolocumab,

Not yet recruiting
  • ASCVD
  • +3 more
  • (no location specified)
Aug 3, 2023

Cardiovascular Diseases, Uric Acid Trial (Allopurinol 200 mg, Optional intervention)

Not yet recruiting
  • Cardiovascular Diseases
  • Uric Acid
  • Allopurinol 200 mg
  • Optional intervention
  • (no location specified)
Jul 5, 2023

Atherosclerotic Cardiovascular Disease Trial (Atozet 10/40 mg or 10/80 mg, Lipitor 40 mg or 80 mg)

Not yet recruiting
  • Atherosclerotic Cardiovascular Disease
  • Atozet 10/40 mg or 10/80 mg
  • Lipitor 40 mg or 80 mg
  • (no location specified)
Mar 8, 2023

Dyslipidemia in Patients at High Risk and Very High Risk of

Recruiting
  • Secondary Prevention
  • +2 more
  • application
  • Leon, Guanajuato, Mexico
    Umae Cmn T1
Sep 13, 2022

Allogeneic Hematopoietic Stem Cell Transplantation, Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Suzhou

Recruiting
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +2 more
  • VEN+AZA+Modified BUCY
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Apr 10, 2023

Acute Myeloid Leukemia (AML), High-risk Myelodysplastic Syndrome (MDS) Trial in Worldwide (HDM201, MBG453, Venetoclax)

Active, not recruiting
  • Acute Myeloid Leukemia (AML)
  • High-risk Myelodysplastic Syndrome (MDS)
  • Durham, North Carolina
  • +8 more
Dec 13, 2022

Acute Myeloid Leukemia, High-Risk and Very High-Risk MDS Trial (SGR-2921)

Not yet recruiting
  • Acute Myeloid Leukemia
  • High-Risk and Very High-Risk Myelodysplastic Syndromes
  • (no location specified)
Jul 25, 2023

Acute Cholecystitis Trial in Hong Kong (Endoscopic ultrasound-guided gallbladder drainage, Antibiotics first)

Recruiting
  • Acute Cholecystitis
  • Endoscopic ultrasound-guided gallbladder drainage
  • Antibiotics first
  • Hong Kong, Hong Kong
    The Chinese Universtiy of Hong Kong
May 29, 2023

Myelodysplastic Syndrome, Allogeneic Hematopoietic Stem Cell Transplantation, Conditioning Trial in Guangzhou (Granulocyte

Recruiting
  • Myelodysplastic Syndrome
  • +2 more
  • Granulocyte Colony-Stimulating Factor(G-CSF)
  • +5 more
  • Guangzhou, Guangdong, China
    Department of Hematology,Nanfang Hospital, Southern Medical Univ
Jul 11, 2022

Bronchopulmonary Dysplasia, Child Development, Neonatal and Perinatal Conditions Trial in Québec (High-dose DHA, Control)

Not yet recruiting
  • Bronchopulmonary Dysplasia
  • +2 more
  • High-dose DHA
  • Control
  • Québec, Quebec, Canada
    CHU de Québec-Université Laval
Jun 20, 2023

Acute Myeloid Leukemia, MDS Trial in Hangzhou (Decitabine for Injection, VENCLYXTO)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndromes
  • Hangzhou, Zhejiang, China
    The First Affiliated Hospital, College of Medicine, Zhejiang Uni
Sep 18, 2023

AML, Adult Recurrent, MDS Trial in United States (LYT-200)

Recruiting
  • AML, Adult Recurrent
  • MDS
  • Los Angeles, California
  • +13 more
Apr 12, 2023